Breast cancer mortality can drop significantly among women who undergo screening.
Breast cancer mortality can drop as much as 49 percent among women who undergo cancer screening, say Australian researchers in an article published in the September 10 issue of Cancer Epidemiology, Biomarkers & Prevention.
The researchers from the University of Melbourne studied 427 women who died of breast cancer who were each matched with up to 10 controls, for a total of 3,650 controls. The number of breast cancer screenings for the women in both groups were then compared.
The association between screening participation and breast cancer mortality was estimated, as well as quantifying the effect of potential sources of bias, including selection bias, information bias, and confounding. The authors also conducted a meta-analysis of published case-control studies.
It was found that the women who had died of breast cancer had undergone fewer screening procedures through the Western Australian BreastScreen Program than did the controls.
The odds ratio for screening in relation to death from breast cancer was 0.48. The researchers wrote that they were unable to identify biases that could negate the findings.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.